China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap11.4B
Enterprise Value11.16B
P/E Ratio-109.96
PEG Ratio1.4
Price/Sales Ratio4.2
Price/Book Ratio0.96
Enterprise/Revenue3.84
Enterprise/EBITDA-417.13

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.04
Operating Margin-0.13
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.01

Income Statement

Revenue2.05B
Revenue/Share3.36
Gross Profit936.88M
EBITDA270.13M
Net Income112.7M
Diluted EPS0.22

Balance Sheet

Total Cash2.82B
Total Cash/Share5.6
Total Debt161.86M
Total Debt/Equity0.02
Current Ratio7.17
Book Value Per Share14.79

Price History

52-Week Change-45.17
52-Week High25.82
52-Week Low13.64
Moving Average 50 Days15.15
Moving Average 200 Days18.72

Statistics

Average Volume7.03M
Shares Outstanding504.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.22
Trailing Annual Dividend Yield1.58
Payout Ratio-1.24
Last Split Factor3:2
Last Split DateMay 26, 2017
AD